As shown in Supplementary Figure 3, high FNDC3B expression levels were associated with poorer prognosis of OS and disease-free survival (DFS) in adrenocortical carcinoma (ACC), GBM, kidney Chromophobe (KICH), LGG, liver hepatocellular carcinoma (LIHC), mesothelioma (MESO), and pancreatic adenocarcinoma (PAAD); OS in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) and lung adenocarcinoma (LUAD); DFS in colon adenocarcinoma (COAD) and uveal Melanoma (UVM). Here, FNDC3B is linked to colon adenocarcinoma.